BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Souza BK, Freire NH, Jaeger M, de Farias CB, Brunetto AL, Brunetto AT, Roesler R. EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors. Int J Mol Sci 2021;22:11292. [PMID: 34681949 DOI: 10.3390/ijms222011292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang N, Das D, Shankar SR, Goy P, Guccione E, Taneja R. An interplay between BRD4 and G9a regulates skeletal myogenesis. Front Cell Dev Biol 2022;10:978931. [DOI: 10.3389/fcell.2022.978931] [Reference Citation Analysis]
2 Ang GCK, Gupta A, Surana U, Yap SXL, Taneja R. Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2. Cancers (Basel) 2022;14:2855. [PMID: 35740522 DOI: 10.3390/cancers14122855] [Reference Citation Analysis]
3 Souza BK, Freire NH, Jaeger M, de Farias CB, Brunetto AL, Brunetto AT, Roesler R. G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma. Neuromolecular Med 2022. [PMID: 35113321 DOI: 10.1007/s12017-022-08702-5] [Reference Citation Analysis]